Burning Rock Biotech (BNR) Assets (2019 - 2026)

Burning Rock Biotech (BNR) has reported Assets for 8 consecutive years, with $114.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets fell 3.04% year-over-year to $114.2 million; the TTM figure through Mar 2026 stood at $114.2 million (down 3.04% YoY), while the FY2025 annual figure was $117.3 million, down 3.28% from the prior year.
• Assets came in at $114.2 million for Q1 2026 at Burning Rock Biotech, down from $115.7 million in the prior quarter.
• The five-year high for Assets was $332.5 million in Q1 2022, with the low at $114.1 million in Q3 2025.
• Average Assets over 5 years is $169.9 million, with a median of $140.8 million recorded in 2024.
• Across the five-year window, Assets slumped 37.93% in 2023 and decreased 3.04% in 2026, its largest moves.
• Year by year, Assets stood at $223.2 million in 2022, then plunged by 35.29% to $144.4 million in 2023, then retreated by 14.67% to $123.2 million in 2024, then fell by 6.15% to $115.7 million in 2025, then declined by 1.26% to $114.2 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $114.2 million, $115.7 million, and $114.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.